DNA

Ginkgo Bioworks Holdings Inc
Health CareUSCUSIP 37611X209◍ Confluence graph
Tracked 13F Holders
166
-90 QoQ
13F Value (tracked)
$224.7M
Insider Net · 180d
-$3.6M
0↑ 4↓
Recent Filings
15
Smart-money sentimentMixed
BearishBullish
13F funds (latest Q)28 adding · 15 trimming
Insider net (180d)-$3.6M

Who owns DNA?

166 tracked 13F filers

166 tracked 13F filers disclose a position in DNA as of the latest SEC 13F filings, a combined $224.7M in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

All quarters use one ordinary-share-equivalent series. Historical ADS are converted at 2 ADS = 1 ordinary share. Expand a row for the exact calculation; the residual is not classified as a trade.
#FundPosition valueSharesLast moveAs ofHistory
1BlackRock, Inc.
$22.3M
3.6M
+1.9%
Added · +69K sh
Q1 2026
2VIKING GLOBAL INVESTORS LP
$21.9M
3.6M
Held
Q1 2026
3Erste Asset Management GmbH
$25.9M
2.5M
+30%
Added · +589K sh
Q2 2026
4BAILLIE GIFFORD & CO
$14.7M
2.4M
Held
Q1 2026
5VANGUARD CAPITAL MANAGEMENT LLC
$11.7M
1.9M
First observed position
No prior filed position
Q1 2026
6Legal & General Group Plc
$10.2M
1.7M
+5.3%
Added · +84K sh
Q1 2026
7STATE STREET CORP
$14.6M
1.5M
+9.3%
Added · +126K sh
Q2 2026
8GEODE CAPITAL MANAGEMENT, LLC
$12.1M
1.2M
+21%
Added · +213K sh
Q2 2026
9FORBES J M & CO LLP
$9.9M
1000K
−2.8%
Reduced · −28K sh
Q2 2026
10GOLDMAN SACHS GROUP INC
$5.7M
930K
+1.1%
Added · +11K sh
Q1 2026
11Allianz Asset Management GmbH
$4.3M
701K
+56%
Added · +251K sh
Q1 2026
12SB INVESTMENT ADVISERS (UK) LTD
$3.7M
611K
Held
Q1 2026
13UBS Group AG
$3.6M
583K
+19%
Added · +93K sh
Q1 2026
14VANGUARD PORTFOLIO MANAGEMENT LLC
$3.5M
566K
First observed position
No prior filed position
Q1 2026
15PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.
$5.4M
542K
Held
Q2 2026
16MILLENNIUM MANAGEMENT LLC
$3.0M
488K
+898%
Added · +439K sh
Q1 2026
17BANK OF AMERICA CORP /DE/
$2.9M
477K
−21%
Reduced · −126K sh
Q1 2026
18TUDOR INVESTMENT CORP ET AL
$2.8M
465K
+140%
Added · +271K sh
Q1 2026
19MORGAN STANLEY
$2.8M
460K
−40%
Reduced · −306K sh
Q1 2026
20EXCHANGE TRADED CONCEPTS, LLC
$3.6M
359K
+11%
Added · +37K sh
Q2 2026
21NORTHERN TRUST CORP
$2.0M
334K
+6.7%
Added · +21K sh
Q1 2026
22CHARLES SCHWAB INVESTMENT MANAGEMENT INC
$2.0M
332K
−7.2%
Reduced · −26K sh
Q1 2026
23JACOBS LEVY EQUITY MANAGEMENT, INC
$2.0M
323K
+32%
Added · +78K sh
Q1 2026
24AQR CAPITAL MANAGEMENT LLC
$1.8M
295K
+73%
Added · +124K sh
Q1 2026
25Coastal Bridge Advisors, LLC
$2.7M
277K
Held
Q2 2026

Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

Is DNA being bought or sold by institutions?

Last quarter, 6 funds opened a new position in DNA and 22 added to an existing one, while 15 reduced and 0 exited entirely — based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).

Opened (NEW)
6
funds
Added
22
funds
Reduced
15
funds
Exited
0
funds

Funds that own DNA also own

CompanyCo-held byCombined value
MICROSOFT CORPMSFT81 funds$165.1B
META PLATFORMS INC-CLASS AMETA81 funds$70.0B
NVIDIA CORPNVDA80 funds$246.0B
AMAZON.COM INCAMZN80 funds$117.7B
JPMORGAN CHASE & COJPM77 funds$39.3B
APPLE INCAAPL76 funds$180.5B
MASTERCARD INC - AMA76 funds$35.0B
COSTCO WHOLESALE CORPCOST76 funds$21.3B
INTUITIVE SURGICAL INCISRG76 funds$16.9B
BROADCOM INCAVGO75 funds$91.6B
TESLA INCTSLA75 funds$40.7B
BERKSHIRE HATHAWAY INC-CL BBRK/B75 funds$22.0B

Ranked by how many of DNA's institutional holders also hold each name, a cross-fund conviction signal.

Insider activity (Form 4)

Full insider page →
Buys · 180d
$0
0 insiders
Sells · 180d
$3.6M
4 insiders
Net
-$3.6M
14 P/S txns
Signal
Net Selling
open-market
DateInsiderRoleActionSharesValue
Aug 24, 2026Coen Steven P.See remarksSell (S)330$2K
Jul 17, 2026Coen Steven P.See remarksSell (S)752$6K
May 22, 2026Coen Steven P.See remarksSell (S)307$3K
Apr 17, 2026Coen Steven P.See remarksSell (S)324$3K
Apr 13, 2026Coen Steven P.See remarksSell (S)33K$213K
Apr 10, 2026Shetty Reshma P.See remarks, Director, 10% OwnerSell (S)125K$802K
Apr 10, 2026Canton Barry10% OwnerSell (S)125K$802K
Apr 9, 2026Canton Barry10% OwnerSell (S)13K$84K
Apr 9, 2026Kelly Jason RSee remarks, DirectorSell (S)110K$702K
Apr 9, 2026Shetty Reshma P.See remarks, Director, 10% OwnerSell (S)13K$84K
Apr 8, 2026Canton Barry10% OwnerSell (S)13K$91K
Apr 8, 2026Kelly Jason RSee remarks, DirectorSell (S)97K$672K

Institutional ownership over time

67 funds-33 since Q3 2024
079157Q3 2024Q1 2025Q3 2025Q1 2026Q2 2026
funds holding aggregate valuelatest $84.6M

Share classes

Class13F holdersValue held
DNAthis pagecs166 funds$224.7M
DNA4EURCL A1 funds$29
37611X118Stock1 funds$0

Same issuer, multiple share classes. The consensus leaderboards count this company once across all classes; this is the per-class detail.

Recent filings

15 shown

Keep exploring

Connected entities for DNA

Browse more

Build

Ask your agent what changed in DNA

This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/stocks/DNA/capital-change-brief"
Ask your agent
Use Arkolith's capital_change_brief for DNA.
Tell me what changed, whether insider activity
corroborates it, and cite the SEC evidence.

13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for DNA. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.